Paul Grof, MD, FRCPC Endorses Healthcare Practitioner Access to Psilocybin for Professional Training
TheraPsil’s page presents a letter from Paul Grof, MD, FRCPC supporting healthcare practitioner access to psilocybin for professional training. It explains the need for trained clinicians in psilocybin-assisted psychotherapy and the role of experiential learning in that training model.
Provider
Details
Enrollment
Course Overview
This course page centers on a public letter from Paul Grof, MD, FRCPC, supporting healthcare practitioner access to psilocybin for professional training. The source text describes psilocybin-assisted psychotherapy as a modality that requires specific preparation and familiarity with non-ordinary states of consciousness. The page explains TheraPsil’s training approach, which combines lectures, case studies, readings, discussions, and experiential learning. In the described model, trainees include doctors, therapists, clinical counselors, nurses, social workers, and other healthcare professionals who may participate in psilocybin-assisted psychotherapy training. The page also provides background on TheraPsil’s efforts to secure exemptions for professional training and the shortage of qualified healthcare professionals in this area. It is a professional education resource focused on training rationale and access rather than a detailed standalone syllabus.
Who is this for?
Healthcare professionals involved in psilocybin-assisted psychotherapy, including doctors, therapists, clinical counselors, nurses, and social workers.
Prerequisites
Not stated.
About the Provider
TheraPsil is a Canadian grassroots nonprofit advancing compassionate, legal access to psilocybin-assisted psychotherapy through clinician training, patient advocacy, and legal reform, having trained over 700 healthcare professionals since 2019. The organization assists Canadians in navigating Health Canada's Special Access Program, supports patient-rights litigation in Federal Court, and operates the PsilWell community-funded clinical trial exploring psilocybin-assisted therapy for general wellbeing.
View Therapsil profileCourse Details
- PricePrice on request
- Lifecycle statusDiscontinued
- SkillsIntegrationPsychotherapyPsilocybin TherapyUnderstanding psilocybin-assisted psychotherapyPreparing for psychedelic-supported psychotherapySupporting patients in non-ordinary states of consciousnessRecognizing when to intervene and when not to interveneFacilitating post-integration sessionsApplying experiential learning to clinical trainingPsilocybin-assisted psychotherapy fundamentalsUnderstanding non-ordinary states of consciousnessTherapeutic preparation and supervisionPost-session integration conceptsProfessional training rationale for healthcare practitioners
- Categories
Related Courses
View all coursesATMA Advanced Psychedelic-Assisted Therapy (PAT) Certification Program
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jun 1, 2026
Accredited vs Non-Accredited Psychedelic Training
By AAA Learning Institute
Compare accredited and non-accredited psychedelic training programs, with an overview of what accreditation means and how to evaluate program quality. The page focuses on structure, practicum, curriculum, and practical considerations for prospective psilocybin facilitator students.
Aotearoa New Zealand Psilocybin Training
By Therapsil
A 106-hour live online training in psilocybin-assisted psychotherapy with an Aotearoa New Zealand-specific curriculum, delivered in partnership with PsyTrain. It is designed to support clinical practice with supervised learning and expert faculty input.
Next cohort: Jun 1, 2026